Degeneration of basal forebrain cholinergic neurons is a common feature of Alzheimer's disease and is proposed to be an early and key event in the condition's etiology. This review discusses recent findings that strongly link the p75 neurotrophin receptor (p75 NTR) to both cholinergic neuron degeneration and the production of toxic forms of amyloid-beta (Aß), which is found deposited as amyloid plaques in the brains of Alzheimer's disease patients. Although elucidating the underlying molecular mechanisms and the clinical significance of these findings will require further experimentation, a number of possible scenarios and future research directions are presented.
Auld DS, Kornecook TJ, Bastianetto S., Quirion R.2002. Alzheimer's disease and the basal forebrain cholinergic system: relations to b-amyloid peptides, cognition, and treatment strategies . Prog Neurobiol68:209-45.
2.
Bamji SX, Majdan M., Pozniak CD, Belliveau DJ, Aloyz R., Kohn J., and others. 1998. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J Cell Biol140:911-23.
3.
Bertram L., Tanzi RE2008. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci9:768-78.
4.
Blokland A.1995. Acetylcholine: a neurotransmitter for learning and memory ? Brain Res Brain Res Rev21:285-300.
5.
Capsoni S., Giannotta S., Cattaneo A.2002. b-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies. Mol Cell Neurosci21:15-28.
6.
Capsoni S., Ugolini G., Comparini A., Ruberti F., Berardi N., Cattaneo A.2000. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci U S A97:6826-31.
7.
Costantini C., Rossi F., Formaggio E., Bernardoni R., Cecconi D., Della-Bianca V.2005. Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in b-amyloid peptide-dependent cell death . J Mol Neurosci25:141-56.
8.
Coulson EJ2006. Does the p75 neurotrophin receptor mediate Ab-induced toxicity in Alzheimer's disease? J Neurochem98:654-60.
9.
Coulson EJ, May LM, Osborne SL, Reid K., Underwood CK, Meunier FA, and others. 2008. p75 neurotrophin receptor mediates neuronal cell death by activating GIRK channels through phosphatidylinositol 4,5-bisphosphate . J Neurosci 28:315-24.
10.
Dechant G., Barde YA2002. The neurotrophin receptor p75NTR: novel functions and implications for diseases of the nervous system. Nat Neurosci5:1131-6.
11.
Deinhardt K., Reversi A., Berninghausen O., Hopkins CR, Schiavo G.2007. Neurotrophins redirect p75NTR from a clathrin-independent to a clathrin-dependent endocytic pathway coupled to axonal transport. Traffic8:1736-49.
12.
Fahnestock M., Michalski B., Xu B., Coughlin MD2001. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease . Mol Cell Neurosci18:210-20.
13.
Flood JF, Morley JE1998. Learning and memory in the SAMP8 mouse. Neurosci Biobehav Rev22:1-20.
14.
Francis PT1996. Pyramidal neurone modulation: a therapeutic target for Alzheimer's disease. Neurodegeneration5: 461-5.
15.
Gandy S.2005. The role of cerebral amyloid b accumulation in common forms of Alzheimer disease. J Clin Invest115:1121-9.
16.
Gimenez-Llort L., Blazquez G., Canete T., Johansson B., Oddo S., Tobena A., and others. 2007. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev31:125-47.
17.
Ginsberg SD, Che S., Wuu J., Counts SE, Mufson EJ2006. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem97:475-87.
18.
Hardy J., Selkoe DJ2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science297:353-6.
19.
Hempstead BL, Martin-Zanca D., Kaplan DR, Parada LF, Chao MV1991. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature350:678-83.
20.
Hunter CL, Isacson O., Nelson M., Bimonte-Nelson H., Seo H., Lin L., and others. 2003. Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome . Neurosci Res45:437-45.
21.
Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS1995. The toxicity in vitro of b-amyloid protein. Biochem J311:1-16.
22.
Kaplan DR, Miller FD2000. Neurotrophin signal transduction in the nervous system . Curr Opin Neurobiol10:381-91.
23.
Lowry KS, Murray SS, McLean CA, Talman P., Mathers S., Lopes EC, and others. 2001. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord2:127-34.
Matrone C., Ciotti MT, Mercanti D., Marolda R., Calissano P.2008a. NGF and BDNF signaling control amyloidogenic route and Ab production in hippocampal neurons. Proc Natl Acad Sci U S A105:13139-44.
26.
Matrone C., Di Luzio A., Meli G., D'Aguanno S., Severini C., Ciotti MT, and others. 2008b. Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells. J Alzheimers Dis13:81-96.
27.
Mesulam M.2004. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem11:43-9.
28.
Mufson EJ, Brashers-Krug T., Kordower JH1992. p75 nerve growth factor receptor immunoreactivity in the human brainstem and spinal cord. Brain Res589:115-23.
29.
Mufson EJ, Ma SY, Dills J., Cochran EJ, Leurgans S., Wuu J., and others. 2002. Loss of basal forebrain p75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol443:136-53.
30.
Murphy C., Schubert CR, Cruickshanks KJ, Klein BE, Klein R., Nondahl DM2002. Prevalence of olfactory impairment in older adults . JAMA288:2307-12.
31.
Naumann T., Casademunt E., Hollerbach E., Hofmann J., Dechant G., Frotscher M., and others. 2002. Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J Neurosci22:2409-18.
32.
Ott A., Breteler MMB, van Harskamp F., Claus JJ, van der Cammen TJM, Grobbee DE, Hofman A.1995. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. British Med J310:970-3.
33.
Podlesniy P., Kichev A., Pedraza C., Saurat J., Encinas M., Perez B., and others. 2006. Pro-NGF from Alzheimer's disease and normal human brain displays distinctive abilities to induce processing and nuclear translocation of intracellular domain of p75NTR and apoptosis. Am J Pathol169:119-31.
34.
Rossner S., Ueberham U., Schliebs R., Perez-Polo JR, Bigl V.1998. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog Neurobiol56:541-69.
35.
Roux PP, Bhakar AL, Kennedy TE, Barker PA2001. The p75 neurotrophin receptor activates Akt (protein kinase B) through a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem276:23097-104.
36.
Schliebs R.2005. Basal forebrain cholinergic dysfunction in Alzheimer's disease: interrelationship with b-amyloid, inflammation and neurotrophin signaling . Neurochem Res30:895-908.
37.
Schobel S., Neumann S., Hertweck M., Dislich B., Kuhn PH, Kremmer E., and others. 2008. A novel sorting nexin modulates endocytic trafficking and a-secretase cleavage of the amyloid precursor protein. J Biol Chem283:14257-68.
38.
Selkoe DJ2008. Soluble oligomers of the amyloid b-protein impair synaptic plasticity and behavior. Behav Brain Res192:106-13.
39.
Singh KK, Miller FD2005. Activity regulates positive and negative neurotrophin-derived signals to determine axon competition. Neuron45:837-45.
40.
Singh KK, Park KJ, Hong EJ, Kramer BM, Greenberg ME, Kaplan DR, and others. 2008. Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nat Neurosci11:649-58.
41.
Sotthibundhu A., Sykes AM, Fox B., Underwood CK, Thangnipon W., Coulson EJ2008. β-amyloid1-42 induces neuronal death through the p75 neurotrophin receptor. J Neurosci28:3941-6.
42.
Swaab DF1991. Brain aging and Alzheimer's disease, "wear and tear" versus "use it or lose it." Neurobiol Aging12:317-24.
43.
Underwood CK, Coulson EJ2008. The p75 neurotrophin receptor. Int J Biochem Cell Biol40:1664-8.
44.
Underwood CK, Reid K., May LM, Bartlett PF, Coulson EJ2008. Palmitoylation of the C-terminal fragment of p75NTR regulates death signaling and is required for subsequent cleavage by g-secretase . Mol Cell Neurosci37:346-58.
45.
Urra S., Escudero CA, Ramos P., Lisbona F., Allende E., Covarrubias P., and others. 2007. TrkA receptor activation by nerve growth factor induces shedding of the p75 neurotrophin receptor followed by endosomal g-secretase-mediated release of the p75 intracellular domain. J Biol Chem282:7606-15.
46.
Van der Zee CE, Ross GM, Riopelle RJ, Hagg T.1996. Survival of cholinergic forebrain neurons in developing p75NGFR-deficient mice. Science274:1729-32.
47.
Volosin M., Song W., Almeida RD, Kaplan DR, Hempstead BL, Friedman WJ2006. Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins. J Neurosci26:7756-66.
48.
Yaar M., Zhai S., Pilch PF, Doyle SM, Eisenhauer PB, Fine RE, and others. 1997. Binding of b-amyloid to the p75 neurotrophin receptor induces apoptosis: a possible mechanism for Alzheimer's disease. J Clin Invest100:2333-40.
49.
Yang T., Knowles JK, Lu Q., Zhang H., Arancio O., Moore LA, and others. 2008. Small molecule, non-peptide p75 ligands inhibit Aβ-induced neurodegeneration and synaptic impairment. PLoS ONE3:e3604.
